|
 |
REYATAZThis page contains recent news articles, when available, and an overview of REYATAZ but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.New research suggests that the protease inhibitor (PI) Reyataz (atazanavir), when boosted by low-dose Norvir (ritonavir), might not improve cardiovascular ... AIDSmeds.com HIV/AIDS Treatment News Reyataz and Sustiva Co-Pay Programs Expanded - Dec 18, 2009 Both programs still cover up to $200 a month toward the total cost of co-payments for a regimen containing either Reyataz or Sustiva. ... AIDSmeds.com HIV/AIDS Treatment News Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015 ... - Dec 15, 2009 Viread 9.3.4 Isentress 9.3.5 Trizivir 9.3.6 Kaletra 9.3.7 Reyataz 9.3.8 Combivir 9.3.9 Epzicom/Kivexa 9.3.10 Sustiva Franchise 9.4 Competitive Profiling ... IT News Online Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ... - Dec 10, 2009 The patients were divided into four groups who received Viread and Emtriva or Ziagen and Epivir along with either Norvir (ritonavir)-boosted Reyataz ... The AIDS Beacon (blog) Bristol-Myers Squibb Receives FDA Approval To Update Labeling For Reyataz Capsules - Nov 6, 2009 Bristol-Myers Squibb has reported that FDA has approved a labeling update for Reyataz to include long-term data from the Castle study. ... Pharmaceutical Business Review FDA OKs Labeling Update for Reyataz Capsules - Nov 9, 2009 Data from the study demonstrate enduring virologic response through 96 weeks of treatment with Reyataz/r as part of combination therapy. ... Trading Markets (press release) Bristol-Myers Squibb enters into agreement for ALD518 - Nov 11, 2009 In other Bristol-Myers Squibb news this week, the firm announced that its HIV-1 treatment Reyataz has been granted a label update by the Food and Drug ... Zenopa Bristol-Myers posts higher 3Q sales, lower profit - Oct 22, 2009 ...also boosted the performance for the maker of Abilify, which treats schizophrenia and bipolar disorder, and HIV drugs Sustiva and Reyataz. ... The Associated Press Pharm firms suffer drop after MS drug comes under fire - Oct 25, 2009 Teva has also filed an application to sell a generic version of the Bristol-Myers Squibb AIDS medication Reyataz. Teva made the request pursuant to a ... Ha'aretz Lower Norvir Boosting Dose Possible - Oct 29, 2009 The impact on Reyataz was not consistent, and the researchers suggest it is possible that lower doses of Norvir might also be possible with Reyataz. ... AIDSmeds.com HIV/AIDS Treatment News Ky. has longest waiting list for low-cost drugs for AIDS patients - Oct 31, 2009 A 30-day supply of Reyataz, an antiretroviral drug, can cost $1032 without insurance, they said. KADAP gets its drugs cheaper through a mail-order service ... Kentucky.com Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead's Once ... - Nov 9, 2009 The basic idea is to take a common protease inhibitor, Bristol-Myers Squibb's atazanavir (Reyataz), and swap out a few hydrogen atoms on the molecule with ... Xconomy B-MS posts strong sales for most of its drugs - Oct 23, 2009 As for the firm's HIV drugs, sales of the Sustiva (efavirenz) franchise rose 7% to $315 million, and Reyataz (atazanavir) was up 5% to $360 million. ... Pharma Times Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter - Oct 22, 2009 The virology portfolio continues to demonstrate worldwide sales growth, led by BARACLUDE for hepatitis B (+33%), the Sustiva franchise (+7%) and REYATAZ for ... Reuters Concert: protease inhibitor holds potential to be prescribed un-boosted - Nov 10, 2009 While newer PIs such as Kaletra (lopinavir; Abbott), Reyataz (atazanavir; Bristol-Myers Squibb) and Prezista (darunavir; Tibotec) have addressed many of ... Trading Markets (press release) Ky. AIDS patients waiting longest for meds - Nov 3, 2009 Just one 30-day supply of the anti-retroviral drug Reyataz could cost an uninsured person $1032, officials said. Program officials are able to get the same ... Williamson Daily News News and FDA Updates for S3 Investment (OTC:SIVC), Bristol-Myers (NYSE:BMY) - Nov 7, 2009 On 11/05/09, Bristol-Myers Squibb Company (NYSE:BMY) announced the US Food and Drug Administration (FDA) has approved a labeling update for REYATAZ® to ... American Chronicle Teva Seeks To Sell Generic Version Of Bristol HIV Drug - Oct 22, 2009 ...s (BMY) HIV drug Reyataz. Bristol said in a regulatory filing Thursday that Teva filed its application in October and notified Bristol that it's challenging ... EasyBourse.com Earnings for Two - Oct 22, 2009 Results were driven by Plavix (up 8%) and Abilify (up 16%), Baraclude (up 33%), Sustiva (up 7%), Reyataz (up 5%), Orencia (up 36%) and Sprycell (up 30%). ... TheStreet.com (subscription) Más de la mitad de la población mundial infectada con el virus del VIH son mujeres - Nov 13, 2009 ...un ensayo para determinar la eficacia del antiviral Reyataz, de BMS, en el que apenas se registraron efectos secundarios entre las pacientes tratadas. ... El País (España) Atazanavir et lithiases urinaires - Nov 2, 2009 ...n° 113) attire l'attention sur les effets secondaires à type de calculs urinaires d'un inhibiteur de protéase, l'atazanavir (Reyataz®). ... vih.org הבורסה בת"×? צפויה לפתוח שבוע ×‘× ×˜×™×” לירידות שערי×? - Oct 24, 2009 ...ביו×? שישי פורס×?, ×›×™ טבע מבקשת לשווק גירסה ×’× ×¨×™×ª לתרופה ל×?יידס של בריסטול מ×?יירס - Reyataz. לתרופה מכירות ×©× ×ª×™×•×ª של למעלה מ-1 מילי×?רד דולר ובריסטול בודקת ×?ת ... טלנירי מהלומה למתחרות של טבע בשוק הטרשת ×”× ×¤×•×¦×” - Oct 24, 2009 ...טבע הגישה בקשה לשיווק גרסה ×’× ×¨×™×ª של התרופה Reyataz, שפותחה על ידי בריסטול מיירס סקוויב ומיועדת לטיפול ב×?יידס. טבע הגישה ×?ת הבקשה על פי סעיף 4 לחוק ×”×¥' ... The Marker Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Sep 30, 2008 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD … CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and … - Aug 5, 2008 Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a pre-specified subanalysis of the CASTLE study, in which once-daily boosted ... Genetic Engineering News - Genetic Engineering News (press release) Advertising: Spot for Reyataz Really Speaks to You - Mar 14, 2005 In this era of Web pop-up ads, it might seem that marketers can't get more intrusive. Yet in this month's Out magazine, there's an ad for HIV drug Reyataz ... $2.95 - Newsweek - NewsBank J&J's New AIDS Drug Prezista Outperforms Abbott Pill - Sep 18, 2007 The company is testing Reyataz in a head-to-head trial against Kaletra, ... Sales of Reyataz surged 34 percent last year after a once-daily capsule was ... Bloomberg Bristol-Myers Allows Powerful AIDS Drug to Be Sold Cheaply - Feb 15, 2006 The drug is atanazavir, made by the Bristol-Myers Squibb Company under the brand name Reyataz and introduced only last year in many wealthy countries. ... New York Times Bristol-Myers Grants AIDS Drug Licenses - Feb 14, 2006 The company granted South African company Aspen PharmaCare the rights to manufacture and sell atazanavir, which is called Reyataz in the United States, ... Washington Post Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Sep 30, 2008 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD Norvir/Reyataz Comparable to Kaletra for First-Line Therapy - Feb 4, 2008 By Tim Horn. Data from a study comparing Norvir (ritonavir)-boosted Reyataz (atazanavir) to Kaletra (lopinavir/ritonavir) suggest that both drugs have ... AIDSmeds.com HIV/AIDS Treatment News FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg Single Capsule … - Oct 20, 2006 PRINCETON, NJ, Oct. 20 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the US Food and Drug Administration (FDA) has ... Genetic Engineering News - Genetic Engineering News (press release) More Reports on Kidney Stones With Reyataz - Sep 13, 2007 A French study, published in the September 12 issue of Clinical Infectious Diseases, mirrors another report from the United States suggesting that kidney ... AIDSmeds.com HIV/AIDS Treatment News Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Sep 30, 2008 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD … receives FDA approval for new formulation of antiretroviral Reyataz... - Oct 24, 2006 Bristol-Myers Squibb on Friday announced that it has received FDA approval for a single 300 mg capsule formulation of its protease inhibitor Reyataz to be ... News-Medical.net Reyataz heart risks.(FDA Bits)(Food and drug administration)(Brief... - Apr 1, 2005 Reyataz heart risks.(FDA Bits)(Food and drug administration)(Brief Article) ... find HIV Treatment: ALERTS! articles. New precautions have been added t0the ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research Reyataz May Cause Kidney Stones - Jun 19, 2007 ...by Tim Horn. The US Food and Drug Administration has received 30 reports of kidney stones over a four-year period among HIV-positive patients being treated ... AIDSmeds.com HIV/AIDS Treatment News … Similar Efficacy Between Once-Daily REYATAZ(R) (Atazanavir... - Jul 2, 2008 PRINCETON, New Jersey and UXBRIDGE, England, February 7 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced results from the CASTLE ... ITNews Emcure AIDS drugs to come to the north - Mar 17, 2006 Reyataz® is a prescription medicine used in combination with other medicines to treat people ... Reyataz® does not cure HIV or prevent passing HIV to others. Business Standard 48-Week Clinical Trial Data Provides Information Regarding Switching ... - Nov 18, 2005 ..."Data such as these expand our understanding of the role REYATAZ may play in ... One percent of patients in the REYATAZ arm discontinued due to jaundice or ... Free with registration - PR Newswire - AccessMyLibrary.com Lexiva vs. Reyataz: Comparable Efficacy - Aug 1, 2007 ...by Tim Horn. New data from a study comparing Lexiva (fosamprenavir) to Reyataz (atazanavir), both combined with Norvir (ritonavir), indicates that these ... AIDSmeds.com HIV/AIDS Treatment News … Efficacy Between Once-Daily REYATAZ® (atazanavir Sulfate)/ritonavir... - Feb 10, 2008 In this study, 78 percent of the 440 patients in the REYATAZ/r arm met the ... The REYATAZ/r arm was associated with significantly lower increases from ... Medical News Today - Medical News Today (press release) Press Release: FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg … - Oct 20, 2006 FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg Single Capsule Formulation in Combination Therapy for Adults With HIV-1 Infection. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Clinical Trial Data Reported Comparing REYATAZ(R) (Atazanavir... - Feb 9, 2006 New 48 Week Clinical Trial Data Reported Comparing REYATAZ(R) (Atazanavir Sulfate), With or Without Ritonavir, in Treatment-Naive Patients. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research USA pharma: BMS releases positive Reyataz results - Aug 11, 2008 Bristol-Myers Squibb says that data from the CASTLE study shows that once-daily ritonavir-boosted Reyataz (atazanavir sulfate) and twice-daily lopinavir ... $34.00 - EIU Country Analysis - Alacra Store WSJ Uncovers Abbott's Norvir-Busting Marketing Strategies - Jan 5, 2007 Like Reyataz, Lexiva was showing significant promise as a once-daily Norvir-boosted ... In response to the threat of Norvir-boosted Reyataz and Lexiva on ... AIDSmeds.com HIV/AIDS Treatment News Press Release: 48-Week Clinical Trial Data Provides Information … - Nov 18, 2005 ..."Data such as these expand our understanding of the role REYATAZ may play in ... REYATAZ is the first once-daily protease inhibitor approved by the FDA. ... Pay-Per-View - PR Newswire - HighBeam Research … Clinical Trial Data Reported Comparing REYATAZ(R) (Atazanavir... - Feb 9, 2006 DENVER, Feb. 9 /PRNewswire/ -- Data presented during the Thirteenth Conference on Retroviruses and Opportunistic Infections (CROI) provided results on the ... $4.95 - PR Newswire - ECNext New Drug Interaction Information With Reyataz - Aug 22, 2008 The US Food and Drug Administration (FDA) issued new instructions on potential drug interactions between the protease inhibitor Reyataz (atazanavir) and ... AIDSmeds.com HIV/AIDS Treatment News Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning … - Apr 16, 2007 I salute the winners of the REYATAZ 'Fight HIV Your Way' Photography Contest for the ... REYATAZ does not cure HIV or help prevent passing HIV to others. ... Free with registration - PR Newswire - AccessMyLibrary.com ICAAC: Norvir-Boosted Lexiva vs. Reyataz - Oct 2, 2006 ...by Tim Horn. October 2, 2006 (AIDSmeds)—Early data from a study comparing Lexiva® (fosamprenavir) to Reyataz® (atazanavir), both combined with low-dose ... AIDSmeds.com HIV/AIDS Treatment News Reyataz heart risks.(FDA Bits)(Food and drug administration)(Brief... - Apr 1, 2005 New precautions have been added t0the labeling for Reyataz (an HIV protease inhibitor) for patients with existing heart problems. ... $4.95 - HIV Treatment: ALERTS! - ECNext … Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir... - Feb 6, 2008 CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in ... Pay-Per-View - PR Newswire - HighBeam Research Approvals: Herceptin, Reyataz, and Peg-Intron - May 21, 2007 May 21, 2007 — The European Commission has approved a new indication for trastuzumab infusion, allowing its use with hormonal therapy in the treatment of ... Medscape New drug funding for HIV sufferers - Nov 2, 2006 The once-a-day protease inhibitor atazanavir (Reyataz) will be funded by Pharmac. Protease inhibitors are taken to stop the HIV virus from reproducing. ... New Zealand Herald Bristol-Myers Squibb Extends Assistance to State AIDS Drug Assistance... - Mar 22, 2005 REYATAZ is a prescription medicine used in combination with other medicines to treat people ... REYATAZ does not cure HIV or prevent passing HIV to others. ... Free with registration - PR Newswire - AccessMyLibrary.com … Similar Efficacy Between Once-Daily REYATAZ(R) (Atazanavir... - Feb 7, 2008 CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (Atazanavir Sulfate)/Ritonavir and Twice-Daily Lopinavir/Ritonavir at 48 Weeks in ... Pay-Per-View - PR Newswire Europe - HighBeam Research Reyataz.(FDA actions in brief)(Brief article) - Jan 1, 2007 FDA approved atazanavir 300-mg single capsules (Reyataz, Bristol-Myers Squibb) as part of a combination regimen for the treatment of HIV-1 infection. Free with registration - Formulary - AccessMyLibrary.com ICAAC: Trizivir vs. Reyataz/Combivir - Oct 3, 2006 ...by Tim Horn. October 3, 2006 (AIDSmeds)—A new study suggests that 48 weeks of treatment with Trizivir® is comparable to a protease inhibitor-based regimen. ... AIDSmeds.com HIV/AIDS Treatment News 'AIDS Drug Prices to Die For' - AIDS Healthcare Foundation Targets … - Feb 23, 2007 ..."In Mexico, Bristol-Meyers Squibb charges four times as much for Reyataz and ... In 2004, Bristol-Myers Squibb's revenues for Reyataz were US$369 million, ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Bristol-Myers Squibb Extends Assistance to State AIDS ... - Mar 22, 2005 Authorization Application for Reyataz contained clinical data from studies ... 05-02-2009 Bristol-Myers Squibb Calls for Entries for the 2009 Reyataz 'Fight ... Pay-Per-View - PR Newswire - HighBeam Research Netherlands Corporate News - 96-Week Data From CASTLE Study … - Oct 26, 2008 Two percent of patients in the REYATAZ/r arm and nine percent of patients ... Six deaths were reported in the REYATAZ/r arm (equal to one percent of total ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Reyataz. - Jan 1, 2007 FDA approved atazanavir 300-mg single capsules (Reyataz, Bristol-Myers Squibb) as part of a combination regimen for the treatment of HIV-1 infection. ... $9.94 - Formulary - Alacra Store Reyataz approved.(RXs)(treatment for human immunodeficiency virus )( … - Nov 20, 2006 The FDA has approved a 300-mg single-capsule formulation of Reyataz in combination therapy for adults with HIV-1 infection. Bristol-Myers Squibb Co. is the ... Free with registration - Chain Drug Review - AccessMyLibrary.com Atazanavir (Reyataz) Meets Standard for Initial HIV Therapy - Aug 1, 2008 By Michael Smith, North American Correspondent, MedPage Today. PARIS, Aug. 1 -- In HIV patients just starting therapy, the protease inhibitor atazanavir ... MedPage Today Reyataz.(FDA actions in brief)(Brief article) - Jan 1, 2007 FDA approved atazanavir 300-mg single capsules (Reyataz, Bristol-Myers Squibb) as part of a combination regimen for the treatment of HIV-1 infection. $4.95 - Formulary - ECNext … : European Commission Approves REYATAZ(R) (Atazanavir Sulfate … - Jun 24, 2008 The European Commission has granted marketing authorization for REYATAZ(R) (atazanavir sulfate 300mg once daily), administered with ritonavir 100 mg once ... Pay-Per-View - PR Newswire Europe - HighBeam Research EC allows durable efficacy data for Reyataz label.(Brief Article) - Jan 30, 2006 US drug major Bristol-Myers Squibb says that the European Commission has approved the inclusion of 96-week data from clinical study AI424-045 towards the ... $4.95 - Pharma Marketletter - ECNext Bristol-Myers is Bullish on Plavix - Jan 25, 2007 ...in Pravachol sales since the cholesterol pill lost patent protection; and sales of the Reyataz HIV treatment jumped to 34 percent to $931 million. Pharmalot Reyataz approved. - Nov 20, 2006 The FDA has approved a 300-mg single-capsule formulation of Reyataz in combination therapy for adults with HIV-1 infection. Bristol-Myers Squibb Co. is the ... $9.94 - Chain Drug Review - Alacra Store FDA approves Reyataz combination for HIV-1 patients. - Nov 10, 2008 FDA approves Reyataz combination for HIV-1 patients. The U.S. Food and Drug Administration has approved the use of Reyataz (atazanavir) 300 mg once daily ... $9.94 - Drug Topics - Alacra Store USA pharma: FDA has clears Reyataz in combo for HIV-1 - Oct 10, 2008 US drug major Bristol-Myers Squibb says that the Food and Drug Administration has approved Reyataz (atazanavir sulfate) 300mg once-daily plus ritonavir ... $34.00 - EIU Country Analysis - Alacra Store CROI: Atazanavir/ritonavir joins other boosted PIs as potential... - Feb 8, 2006 Atazanavir/ritonavir (Reyataz / Norvir) appears to have similar effectiveness to lopinavir/ritonavir (Kaletra) or saquinavir (Invirase)/ritonavir when used ... Aidsmap Reyataz approved.(RXs)(treatment for human immunodeficiency virus )( … - Nov 20, 2006 The FDA has approved a 300-mg single-capsule formulation of Reyataz in combination therapy for adults with HIV-1 infection. Bristol-Myers Squibb Co. is the ... Pay-Per-View - Chain Drug Review - Factiva, from Dow Jones IAC: Unboosted Atazanavir HIV Regimen Found Inferior - Aug 8, 2008 The combination tested was didanosine (Videx), emtricitabine (Emtriva), and atazanavir (Reyataz), all taken once a day, according to Thomas Campbell, MD, ... MedPage Today ALSO NOTED: Orexigen gets positive Phase II results; AnorMED … - Oct 22, 2006 Bristol-Myers Squibb Company announced that the FDA approved a new 300 mg single capsule formulation of Reyataz for the HIV-1 infection in adults as a part ... FierceBiotech Inside Abbott's tactics to protect AIDS drug - Jan 3, 2007 Then, in June 2003, Bristol-Myers Squibb Co. introduced a new protease inhibitor called Reyataz. Bristol-Myers presented a study it funded suggesting that ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Bristol-Myers Squibb Seeks To Expand Access To Its Most Recently … - Feb 20, 2006 Important Information about ReyatazÆ (atazanavir sulfate) Reyataz is a prescription medicine ... Reyataz does not cure HIV or prevent passing HIV to others. ... Medical News Today - Medical News Today (press release) Wall street choice: BMS looks depressed as its MEDS come off-patent. - Jun 1, 2006 Reyataz, an HIV/AIDS therapy; Erbitux, an anticancer agent (sold under license from Imclone Systems); and Orencia, a treatment for rheumatoid arthritis. ... $9.94 - Medical Marketing & Media - Alacra Store … SANITARIOS ESPAÑOLES ELIGEN ATAZANAVIR (REYATAZ®) MEJOR … - Dec 21, 2005 Los premios EDIMSA 2005 han distinguido a atazanavir (Reyataz®), de Bristol-Myers ... Reyataz® ha recibido, este año, otros reconocimientos importantes, ... acceso.com Article: Qld: Increased funding to fight HIV/AIDS - AAP General News... - Nov 27, 2005 Article: Bristol-Myers Squibb Calls for Entries for the 2009 Reyataz ... Wireless News; May 2, 2009 ; 623 words ... ... Calls for Entries for the 2009 ... Pay-Per-View - AAP General News - HighBeam Research La FDA recomienda a quien tome Reyataz tomar al menos ocho vasos de … - Jun 25, 2007 El Reyataz podrÃa provocar cálculos renales. La Administración de Drogas y Alimentos (FDA) de los Estados Unidos ha recibido informes de 30 casos de ... El Universal - El Universal (Venezuela) Press Release: Bristol-Myers Squibb Announces Fourth Quarter and … - Jan 27, 2005 Sales of REYATAZ(R), a protease inhibitor for the treatment of HIV/AIDS launched in ... REYATAZ(R) has achieved a weekly new prescription share of the U.S. ... Pay-Per-View - PR Newswire - HighBeam Research … émet un avis favorable pour l'utilisation de REYATAZ(R) (sulfate... - Apr 28, 2008 Au sein de l'Union européenne, REYATAZ est actuellement indiqué uniquement ... En outre, le groupe REYATAZ/ra été associé à une augmentation du cholestérol ... Caducée.net … gibt positive Meinung für den Einsatz von REYATAZ(R) (Atazanavir... - Apr 28, 2008 In der gesamten EU ist REYATAZ derzeit nur für den Einsatz bei ... Darüber hinaus wurde die REYATAZ/r Gruppe verglichen mit der Lopinavir/r Gruppe mit ... presseportal.ch Ã?ndice de lecciones - Jun 11, 2008 Reyataz es un medicamento anti-VIH que pertenece a la categorÃa de los inhibidores de ... Reyataz evita que las células T que están infectadas con el VIH, ... AIDSmeds.com HIV/AIDS Treatment News … : La Comisión Europea aprueba REYATAZ(R) combinado con otros … - Jun 24, 2008 La Comisión Europea ha autorizado la comercialización de REYATAZ(R) (sulfato de atazanavir 300mg una vez al dÃa), administrado junto con ritonavir 100 mg ... Cotizalia.com … à VIH : la commission européenne accorde une AMM à REYATAZ(R) - Jul 9, 2008 REYATAZ(R), un inhibiteur de protéase, associé au ritonavir, constitue une ... Les patients prenant l'association REYATAZ(R)/ritonavir ont présenté des taux ... Femmes et sida … Comisión Europea aprueba el uso de 'Reyataz' (BMS) como tratamiento... - Jul 7, 2008 La Comisión Europea ha aprobado el uso del primer inhibidor de la proteasa (IP) 'Reyataz' (atazanavir), comercializado por Bristol-Myers Squibb (BMS), ... ecodiario Article: First hepatitis C treatment approved for co-infected... - Apr 1, 2005 Also, because of the known interactions between Reyataz and Viread, ... New precautions have been added t0the labeling for Reyataz (an HIV protease ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research IAC: Simple HIV Regimen Appears Safe and Effective - Aug 13, 2006 The patients switched from their prior protease inhibitor to Reyataz (atazanavir), ... Plasma Reyataz levels were low or undetectable in two of the three ... MedPage Today Canada OKs dose of Bristol-Myers' HIV drug - May 17, 2007 ..."With the Reyataz 300 mg single-capsule formulation approval, Bristol-Myers Squibb now has one pill, once-daily HIV medicine option available in three drug ... United Press International … CASTLE demuestra una eficacia similar entre REYATAZ(R) )/Ritonavir... - Jul 2, 2008 Reyataz es un medicamento de prescripción utilizado en combinación con otros ... En la Unión Europea, Reyataz ha sido aprobado para su uso en el tratamiento ... Cotizalia.com REYATAZ®, уÑ?иленный ritonavir, разрешен в Европе в качеÑ?тве … - Jun 27, 2008 Ð?мериканÑ?каÑ? компаниÑ? Bristol-Myers Squibb получила разрешение ЕвропейÑ?кой комиÑ?Ñ?ии на применение препарата REYATAZ® (Atazanavir Sulfate) 300 мг длÑ? приема ... ФармацевтичеÑ?кий веÑ?тник Reyataz peut être génériqué - Feb 27, 2006 Le géant pharmaceutique Bristol-Myers-Squibb a annoncé le 15 février la signature d'un accord qui autorise la production d'un générique de Reyataz ... survivreausida.net Truvada (tenofovir + emtricitabine) - Mar 1, 2008 Viread, en la tableta de Truvada, puede disminuir los niveles de Reyataz en la sangre y Reyataz puede aumentar los niveles de Viread en la sangre. ... AIDSmeds.com HIV/AIDS Treatment News Accueil / Actualités / Sciences / 0802092213 : Résultat de l''étude … - Feb 9, 2008 Dans cette étude, 78 % des 440 patients du bras REYATAZ/r ont rempli le ... Dans l'Union européenne, REYATAZ est actuellement autorisé uniquement pour les ... Intelink Q1 2005 Bristol-Myers Squibb Earnings Conference Call - Final. - Apr 28, 2005 Reyataz sales nearly doubled from the prior year, bolstered by its European ... Reyataz has broken through the 30% level in terms of weekly new Rxs in the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Accueil / Actualités / Economie / 0806250015 : Bristol-Myers Squibb … - Jun 25, 2008 La Commission européenne a autorisé la mise sur le marché de REYATAZ(R) (sulfate ... Cette décision signifie que la mise en marché de REYATAZ(R) pour le ... Intelink Which Are The Easiest Drug Combinations? (A Look At Fewer Pills and … - Aug 17, 2007 If Reyataz is taken with Norvir, the approved dose is one 300mg Reyataz capsule ... Reyataz is the first protease inhibitor approved by the US Food and Drug ... AIDSmeds.com HIV/AIDS Treatment News HN83 Atazanavir early access - Jul 10, 2007 De firma heeft de merknaam Zrivada laten vallen en in de VS gekozen voor Reyataz. Of dit ook de Europese naam wordt is nog onbekend. Leer de naam Reyataz ... Hiv Vereniging Nederland Press Release: Cure HIV, Inc. and Global Humanceuticals, Inc. Seek … - Aug 8, 2006 Article: FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg Single . ... REYATAZ does not cure HIV, a serious disease, or help prevent ... sulfate) 300 mg ... Pay-Per-View - PR Newswire - HighBeam Research One Drug Holds AIDS At Bay - Aug 14, 2006 In fact, the patient remains on Reyataz monotherapy. The researchers chose Reyataz for study, Swindells said, because it is taken once daily, it is known to ... Space Daily ФинанÑ?овые новоÑ?ти архив КвартальнаÑ? прибыль Bristol-Myers … - Oct 25, 2007 Объемы продаж Ñ?редÑ?тв длÑ? лечениÑ? СПИДа Reyataz и Sustiva также увеличилиÑ?ÑŒ, Ñ?оответÑ?твенно, на 17% до $273 млн. и на 18% до $237 млн. ... K2Kapital Lipodystrophies : le profil favorable de l'atazanavir se confirme - Sep 27, 2005 Parmi les IP les plus récents, Reyataz (atazanavir) présente un avantage ... Disponible depuis 2004 en France, Reyataz est maintenant utilisé chez plus de ... survivreausida.net Loislaw Federal District Court Opinions - MEIJER, INC. v. ABBOTT … - Apr 11, 2008 In 2003, two new PIs, Bristol-Myers Squibb's Reyataz and GSK's Lexiva, were about to ... In July, 2003, Reyataz was successfully introduced to the market. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Loislaw Federal District Court Opinions - IN RE ABBOTT LABORATORIES … - Jul 6, 2006 In 2003, two new PIs, Bristol-Myers Squibb's Reyataz and GlaxoSmithKline's Lexiva, ... In July, 2003, Reyataz was successfully introduced to the market. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Loislaw Federal District Court Opinions - MEIJER, INC. v. … - Aug 27, 2008 In 2003, two new PIs, Bristol-Myers Squibb's Reyataz and GlaxoSmithKline's Lexiva, ... In July, 2003, Reyataz was successfully introduced to the market. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Loislaw Federal District Court Opinions - IN RE ABBOTT LABORATORIES … - May 16, 2008 In 2003, two new PIs, Bristol-Myers Squibb's Reyataz and GlaxoSmithKline's Lexiva, ... In July, 2003, Reyataz was successfully introduced to the market. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Mead Johnson to go Public - Apr 25, 2008 The first data comparing boosted REYATAZ® (REYATAZ plus ritonavir) and ... The CASTLE study showed similar efficacy between once-daily REYATAZ (atazanavir ... insideindianabusiness.com Studies Disagree on Abacavir for Patients With High Viral Loads - Aug 12, 2008 One group started a regimen containing Epzicom and Sustiva (efavirenz), another started a regimen containing Epzicom and Norvir (ritonavir)-boosted Reyataz ... AIDSmeds.com HIV/AIDS Treatment News OnMedica - News: The European Commission has approved a new label … - Jan 20, 2006 ..."The Reyataz/ritonavir regimen continued to demonstrate comparable efficacy to the ... It added that patients in the Reyataz/ritonavir arm of the trial also ... OnMedica FDA Notifications. - Apr 1, 2005 Until data are available, clinicians should note the following statements from the atazanavir (Reyataz) package insert: "Reduced plasma concentrations of ... Pay-Per-View - AIDS Alert - Factiva, from Dow Jones Un fármaco para enfermos de sida no tratados provoca menos efectos … - Oct 27, 2008 Asà la diferencia entre pacientes tratados con ´Kaletra´ y ´Reyataz´ fue ... Para el doctor Moreno ´Reyataz´ ofrece "un perfil de toxicidad lipÃdica ... Medicinatv.com Bristol-Myers gives two drug makers royalty-free licenses to make and... - Feb 15, 2006 Reyataz was approved in the United States in 2003, and last year its sales ... Bristol-Myers does sell Reyataz at no profit sub-Saharan Africa as it does ... Pay-Per-View - AP Worldstream - HighBeam Research Press Release: Broadway Actress/HIV Advocate, Sheryl Lee Ralph, … - Apr 16, 2007 Traveling Exhibit of REYATAZ(R) (atazanavir sulfate) 'Fight HIV Your Way' ... I salute the winners of the REYATAZ 'Fight HIV Your Way' Photography Contest ... Pay-Per-View - PR Newswire - HighBeam Research Bristol-Myers profit slips; may sell part of nutritional division -... - Apr 24, 2008 Sales of Bristol-Myers' HIV drugs, Reyataz and Sustiva, also performed well. Reyataz sales came in at $297 million for the latest quarter, up 13%, ... MarketWatch Bristol-Myers Tweaks Guidance Down - Oct 27, 2005 Sales of the schizophrenia drug Abilify jumped to $260, up 58% from the year-ago quarter, and the HIV/AIDS drug Reyataz gained 66% to $176 million. ... TheStreet.com - TheStreet.com (subscription) India, Africa get free HIV drug license - Mar 3, 2006 Bristol Myers-Squibb will license its anti-retroviral drug Reyataz royalty-free to two drug makers in Africa and India. Generic drug firms Aspen Pharmacare ... Gate2Biotech FDA OKs boosted combo of Bristol-Myers drug for HIV patients - Oct 4, 2008 REYATAZ, approved by the FDA in 2003, boosted with ritonavir and taken once daily ... "Boosted REYATAZ provides health care professionals a newly approved, ... Scarlet Scuttlebutt - Scarlet Scuttlebutt Is Once-Daily Kaletra an Effective Dosing Option? - Oct 30, 2007 The study looked at drug levels in the blood of people taking Kaletra once daily or twice daily, or Norvir-boosted Reyataz (atazanavir). ... AIDSmeds.com HIV/AIDS Treatment News Bristol-Myers Profit Falls as Plavix Copy Hurts Sales - Oct 26, 2006 Sales of the HIV drug Reyataz, first approved by US regulators in 2003, grew 32 percent to $233 ... A 300-milligram dose of Reyataz got US approval Oct. 20. ... Bloomberg Schaeffer's Today's Market Features: Caterpillar, AstraZeneca,... - Oct 20, 2006 Reyataz is drug that blocks the action of an enzyme that is needed for the virus to ... The single capsule formulation, which can replace two Reyataz 150 mg ... Free with registration - Business Wire - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |